Caraco Laboratories v. Novo Nordisk
Sign up to make a prediciton!
|Case Term||OT 2011|
|Question Presented||Whether a generic drug manufacturer may sue the company that produces the brand-name version of the drug to require it to correct information filed with the FDA that is relevant to the agency’s decision whether to approve the generic version of the drug.|
|Lower Court's Decision||No|
|Research for TWEN users
Outcome - Reverse
This case was decided on 17 April, 2012.